Colony Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-18,579
| Closed | -$1.21M | – | 729 |
|
|
2019
Q4 | $1.21M | Sell |
18,579
-2,507
| -12% | -$163K | 0.03% | 374 |
|
|
2019
Q3 | $1.31M | Sell |
21,086
-2,071
| -9% | -$129K | 0.04% | 328 |
|
|
2019
Q2 | $1.65M | Buy |
23,157
+21
| +0.1% | +$1.5K | 0.05% | 305 |
|
|
2019
Q1 | $1.81M | Buy |
23,136
+1,640
| +8% | +$129K | 0.08% | 217 |
|
|
2018
Q4 | $1.82M | Buy |
21,496
+1,802
| +9% | +$153K | 0.09% | 193 |
|
|
2018
Q3 | $3.37M | Sell |
19,694
-424
| -2% | -$72.6K | 0.17% | 125 |
|
|
2018
Q2 | $2.6M | Sell |
20,118
-9,733
| -33% | -$1.26M | 0.14% | 151 |
|
|
2018
Q1 | $3.08M | Sell |
29,851
-478
| -2% | -$49.3K | 0.17% | 129 |
|
|
2017
Q4 | $2.59M | Sell |
30,329
-2,789
| -8% | -$238K | 0.16% | 134 |
|
|
2017
Q3 | $2.81M | Sell |
33,118
-1,986
| -6% | -$169K | 0.19% | 110 |
|
|
2017
Q2 | $2.66M | Sell |
35,104
-409
| -1% | -$31K | 0.19% | 114 |
|
|
2017
Q1 | $2.35M | Sell |
35,513
-697
| -2% | -$46K | 0.22% | 107 |
|
|
2016
Q4 | $2.3M | Buy |
36,210
+146
| +0.4% | +$9.25K | 0.25% | 98 |
|
|
2016
Q3 | $2.3M | Sell |
36,064
-1,090
| -3% | -$69.4K | 0.26% | 83 |
|
|
2016
Q2 | $2.76M | Sell |
37,154
-933
| -2% | -$69.4K | 0.3% | 69 |
|
|
2016
Q1 | $2.54M | Sell |
38,087
-96
| -0.3% | -$6.41K | 0.29% | 70 |
|
|
2015
Q4 | $2.58M | Buy |
38,183
+368
| +1% | +$24.9K | 0.24% | 97 |
|
|
2015
Q3 | $2.02M | Buy |
+37,815
| New | +$2.02M | 0.23% | 98 |
|